Summary
The complement system is an excellent one to look at as an example of a triggered enzyme system. It is found to use almost all the strategies of enzyme cascades and for initiation which were discussed in the introduction. The classical pathway is a fine example of an active zymogen form of activation and the alternative pathway is the canonical example of a tickover. Both may also be activated by exogenous enzymes from other systems. The strategies of enzymes waiting for substrates, of substrates waiting for enzymes, and of both waiting for modifying proteins are all seen in various stages of the reaction. There is an association of a linear cascade with the positive feedback amplification loop. This degree of evolutionary adaptation is not only aesthetically pleasing but must be taken to mean that the system is of considerable biological importance and has been over a long evolutionary time span.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abramson N, Alper CA, Lachmann PJ, Rosen FS, Jandl JH (1971) Deficiency of C3 inactivator in man. J Immunol 155: 96
Bartholomew RM, Esser AF (1980) Mechanism of antibody-independent activation of the first component of complement (C1). Biochemistry 19: 2847
Borsos T, Rapp HJ (1965) Complement fixation on cell surfaces by 19S and 7S antibodies. Science 150: 505
Borsos T, Chapuis RM, Langone JJ (1981) Distinction between fixation of C1 and the activation of complement by natural IgM antihapten antibody: effect of cell surface hapten density. Mol Immunol 18: 863
Colomb MG, Bensa JC, Villier CL, Arlaud GJ (1982) Aspects biochimiques de l'activation intrinsique de C1. Ann Immunol (Paris) 133C: 155
Cotten HR, Borsos T, Rapp JR (1969) Titration of the first component of complement on a molecular basis: suitability of IgM and non-suitability of IgG haemolysins as sensitizers. Immunochemistry 6: 461
Emanuel EJ, Brampton AD, Baston DR, Dwek RA (1982) Formation of complement subcomponent C1q-immunoglobulin G complex. Biochem J 205: 361
Esser AF (1982) Interactions between complement proteins and biological and model membranes. In: Chapman D (ed) Biological membranes. Academic Press, London, p 277
Fearon DT, Austen KF (1977) Activation of the alternative pathway with rabbit erythrocytes by circumvention of the regulatory action of endogenous control proteins. J Exp Med 146: 22
Feinstein A, Beale D (1977) Models of immunoglobulins and antigen-antibody complexes. In: Glynn LE, Steward MW (eds) Immunochemistry, and advanced text book. Wiley, Chichester, p 263
Feinstein A, Richardson NE, Gorick BD, Hughes Jones NC (1983) Immunoglobulin M conformational change is a signal for complement activation. In: Celada F, Shumaker VN, Sercarz EE (eds) Protein conformation as an immunological signal. Plenum Press, New York, p 47
Folkerd EJ, Gardner B, Hughes-Jones NC (1980) The relationship between the binding ability and the rate of activation of the complement component C1. Immunology 41: 179
Goers JW, Ziccardi RJ, Schumaker VN, Glovsky MM (1977) The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex. J Immunol 118: 2182
Hughes-Jones NC (1977) Functional affinity constants of the reaction between125I-labelled C1q and C1q binders. Immunology 32: 191
Hughes-Jones NC, Gardner B (1979) Reaction between the isolated globular sub-units of the complement component C1q and IgG complexes. Mol Immunol 16: 697
Hughes-Jones NC, Ghosh S (1981) Anti-D-coated Rh-positive red cells will bind the first component of the complement pathway, C1q. FEBS Lett 128: 318
Hughes-Jones NC, Gorick BD, Howard JC (1983) The mechanisms of synergistic complementmediated lysis of rat red cells by monoclonal IgG antibodies. Eur J Immunol 13: 635
Humphrey JH, Dourmashkin RR (1965) Electron microscopy studies of immune cell lysis. In: Wolstenholme GEW, Knight J (eds) Complement. Churchill, London, p 175
Humphries GMK, McConnell HM (1977) Membrane-controlled depletion of complement activity by spin-label specific IgM. Proc Natl Acad Sci USA 74: 3537
Karush F, Chua M-M, Rodwell JD (1979) Interaction of a bivalent ligand with IgM anti-lacton antibody. Biochemistry 18: 2226
Kazatchkine MD, Fearon DT, Austen KF (1979) Human alternative pathway: membrane associated sialic acid regulates the competition between B and B1H for cell bound C3b. J Immunol 122: 75
Klein M, Haeffner-Cavaillou N, Isenman DE, Rivat C, Mavia NA, Davies DR, Dorrington KJ (1981) Expression of biological effector functions by immunoglobulin G molecules lacking the hinge region. Proc Natl Acad Sci USA 78: 524
Knobel HR, Villiger W, Isliker H (1975) Chemical analysis and electron microscopy studies of human Clq prepared by different methods. Eur J Immunol 5: 78
Lachmann PJ (1979) An evolutionary view of the complement system. Behring Inst Mitt 63: 25
Lachmann PJ, Müller-Eberhard HJ (1968) The demonstration in human serum of “conglutinogen-activating factor” and its effect on the third component of complement. J Immunol 100: 691
Liberti PA, Bansch DM, Schoenberg LM (1982) On the mechanism of C1q binding to antibody. I. Aggregation and distribution of the IgG versus combining site-transmitted effects. Mol Immunol 19: 143
Loos M (1982) Antibody-independent activation of C1, the first component of complement. Ann Immunol (Paris) 133: C 165
Lukas TJ, Munoz H, Erickson BW (1981) Inhibition of C1-mediated immune haemolysis by monomeric and dimeric peptides from the second constant domain of human immunoglobulin G. J Immunol 127: 2555
Macfarlane RG (1969) The blood clotting mechanism. The development of a theory of blood coagulation. Proc R Soc London Ser B 173: 261
Medicus RG, Arnaout MA (1982) Release of C3c from bound C3bi by C3b inactivator. Mol Immunol 19: 1386.
Medof ME, Iida K, Mold C, Nussenzweig V (1982) Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med 156: 1739
Meyer CM, Colomb MG (1976) Use of an IgG fragment prepared with particulate plasma to study C1 binding and activation. FEBS Lett 66: 132
Naff GB, Ratnoff OD (1968) The enzymatic nature of C1r. J Exp Med 128: 571
Nicol PAL, Lachmann PJ (1973) The alternative pathway of complement activation: the role of C3 and its inactivator (KAF). Immunology 24: 135
Painter RH, Foster DB, Gardner B, Hughes-Jones NC (1982) Functional affinity constants of subfragments of immunoglobulin G for C1q. Mol Immunol 19: 127
Pangburn MK, Schreiber RD, Müller-Eberhard HJ (1981) Formation of the initial C3 convertase of the alternative pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thiolester bond in native C3. J Exp Med 154: 856
Price JW, McConnell HM, Bartholomew RM, Esser AF (1980) Kinetics of antibody-dependent activation of the first component of complement on lipid bilayer membranes. Biochem Biophys Res Commun 93: 235
Reid KBM, Porter RR (1976) Subunit composition and structure of subcomponent Clq of the first component of human complement. Biochem J 155: 19
Reid KBM, Gagnon H, Frampton J (1982) Completion of the amino acid sequences of the A and B chains of subcomponent C1q of the first component of human complement. Biochem J 203: 559
Rochna E, Hughes-Jones NC (1965) The use of purified125I-labelled antiglobulin in the determination of the numbers of D antigen sites on red cells of different phenotypes. Vox Sang 10: 675
Ross GD, Lambris JD, Cain JA, Newman SL (1982) Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for Factor H versus CR1 cofactor activity. J Immunol 129: 2051
Rosse WF, Rapp HJ, Borsos T (1967) Structural characteristics of haemolytic antibodies as determined by the effects of ionizing radiation. J Immunol 98: 1190
Schumaker VN, Calcott MA, Spiegelberg HL, Muller-Eberhard HJ (1976) Ultracentrifuge studies of the binding of IgG of different subclasses to the C1q subunit of the first component of complement. Biochemistry 15: 5175
Schumaker VN, Poon PH, Seegan GW, Smith CA (1981) Semiflexible joint in the C1q subunit of the first component of human complement. J Mol Biol 148: 191
Siegel RC, Schumaker VN (1983) Measurements of the association constants of the complexes between intact C1q or pepsin-treated C1q stalks and the unactivated or activated C1r2C1s2 tetramers. Mol Immunol 20: 53
Svehag SE, Bloth B (1970) The ultrastructure of human C1q. Acta Pathol Microbiol Scand B 78: 260
Thompson RA, Winterborn MH (1981) Hypocomplementaemia due to a genetic deficiency of B1H globulin. Clin Exp Immunol 46: 110
Tschopp J, Shulthers T, Engel J, Jaton J-C (1980) Antigen-independent activation of the first component of complement C1 by chemically cross-linked rabbit IgG oligomers. FEBS Lett 112: 152
Tschopp J, Villiger W, Fuchs H, Kilcherr E, Engel J (1980) Assembly of subcomponents C1r and C1s of the first component of complement. Proc Natl Acad Sci USA 77: 7014
Wiggins RC, Cochrane CG, Griffin JH (1979) Rabbit blood coagulation Factor XI. Mechanism of activation of rabbit Hageman factor (Factor XII). Thromb Res 15: 475
Ziccardi RJ (1982) A new role for\(\overline {Cl}\)-inhibitor in homeostasis: control of activation of the first component of human complement. J Immunol 128: 2505
Hughes-Jones NC, Gorick BD (1982) The binding and activation of the C1r-C1s subunit of the first component of human complement. Mol Immunol 19: 1105
Ziccardi RJ, Cooper NR (1976) Physicochemical and functional characterization of the C1r subunit of the first complement component. J Immunol 116: 406
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lachmann, P.J., Hughes-Jones, N.C. Initiation of complement activation. Springer Semin Immunopathol 7, 143–162 (1984). https://doi.org/10.1007/BF01893018
Issue Date:
DOI: https://doi.org/10.1007/BF01893018